IFNG and neoplasm: Notably, substantial evidence has suggested that gene signatures associated with the IFNG response reliably predict prognosis and responsiveness to ICB of tumor sufferers (4, 9), while developing IFNG-related gene signature for both GBM and lower-grade glioma (LGG) was less addressed.